LOOMIS SAYLES & CO L PLOOMIS SAYLES & CO L P

Institutional investor · Portfolio as of Q4 2023

Top Holdings970 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

META PLATFORMS INC-CLASS A

10.9M$3.9B5.9%$138.14+154.46%
21 qtrssince 2018-Q4
Decreased
0

NVIDIA CORP

7.6M$3.8B5.8%$16.58+198.49%
20 qtrssince 2019-Q1
Decreased
0

AMAZON.COM INC

20.7M$3.2B4.8%$106.79+42.28%
21 qtrssince 2018-Q4
Decreased
0

BOEING CO/THE

10.6M$2.8B4.2%$181.12+43.92%
21 qtrssince 2018-Q4
Decreased
0

VISA INC-CLASS A SHARES

10.3M$2.7B4.1%$131.58+93.81%
21 qtrssince 2018-Q4
Decreased
0

ALPHABET INC-CL A

18.5M$2.6B4.0%$94.66+46.45%
21 qtrssince 2018-Q4
Decreased
0

TESLA INC

10.1M$2.5B3.8%$225.51+10.19%
14 qtrssince 2020-Q3
Decreased
0

MICROSOFT CORP

6.5M$2.4B3.7%$98.70+273.05%
21 qtrssince 2018-Q4
Decreased
0

NETFLIX INC

4.5M$2.2B3.4%$29.20+66.74%
14 qtrssince 2020-Q3
Decreased
0

ORACLE CORP

19.2M$2B3.1%$40.87+151.67%
21 qtrssince 2018-Q4
Decreased
0

SALESFORCE.COM INC

7.3M$1.9B2.9%$172.07+50.32%
16 qtrssince 2020-Q1
Decreased
0

AUTODESK INC

6.2M$1.5B2.3%$131.92+84.57%
21 qtrssince 2018-Q4
Decreased
0

MONSTER BEVERAGE CORP

26M$1.5B2.3%$39.25+46.78%
21 qtrssince 2018-Q4
Decreased
0

WALT DISNEY CO/THE

14.5M$1.3B2.0%$121.30-27.04%
21 qtrssince 2018-Q4
Increased
55

VERTEX PHARMACEUTICALS INC

3.1M$1.3B2.0%$186.49+118.19%
17 qtrssince 2019-Q4
Decreased
0

REGENERON PHARMACEUTICALS

1.2M$1.1B1.6%$360.72+141.20%
21 qtrssince 2018-Q4
Decreased
0

SHOPIFY INC - CLASS A

13.7M$1.1B1.6%$35.60+118.84%
9 qtrssince 2021-Q4
Decreased
0
NVONVO
ADR

NOVO-NORDISK A/S-SPONS ADR

9M$931.4M1.4%$50.10+89.32%
21 qtrssince 2018-Q4
Decreased
0

QUALCOMM INC

6.2M$889.8M1.4%$48.19+187.85%
21 qtrssince 2018-Q4
Decreased
0

STARBUCKS CORP

8.6M$830.1M1.3%$62.88+42.37%
21 qtrssince 2018-Q4
Decreased
0
$65.3B
AUM
970
Positions
Q4 2023
Filing
4.5/5
HI score
Quarterly 13F Value Change
-8%Q3'22$49.4B+1%Q4'22$49.9B+15%Q1'23$57.6B+8%Q2'23$62B-6%Q3'23$58.2B+12%Q4'23$65.3B
Activity profile
$ moved · Q4'23
New4%Increased17%Decreased73%Exited6%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.3 years
<1Q5%1-4Q10%1-2Y10%2Y+75%

LOOMIS SAYLES & CO L P manages $65.3B across 970 positions as of Q4 2023. Top holdings: META (5.9%), NVDA (5.8%), AMZN (4.8%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4.5/5.0.

Q4 2023 Summary

Active quarter - 165 new positions, 102 exits, 252 increased. Top move: DIS (INCREASED, conviction 55). Portfolio: $65.3B across 970 positions.

Top holdings by portfolio weight

Total AUM$65B
META5.93%
NVDA5.76%
AMZN4.83%
BA4.21%
V4.09%
GOOGL3.96%
TSLA3.83%
MSFT3.75%
NFLX3.37%
ORCL3.09%
Other2.93%

Portfolio allocation by GICS sector

Sectors11
Technology27.43%
Communication Services17.09%
Consumer Cyclical15.46%
Healthcare13.35%
Financial Services10.34%
Industrials9.62%
Consumer Defensive3.59%
Energy1.19%
Unknown0.95%
Basic Materials0.76%
Other0.20%

Behavioral investing profile

7-dimension, SEC 13F-derived research score
Elite(4.5 / 5.0)
Holdings P&L68
Conviction40
Concentration80
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
BKNGBKNGBOOKING HOLDINGS INC
Q3 2024 Q2 2026+3.4M shares+$607.5M
6Q
CEMBCEMBISHARES INC
Q1 2025 Q2 2026+144,626 shares+$6.8M
5Q
TTTTINGERSOLL-RAND PLC
Q2 2025 Q2 2026+284,022 shares+$187M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used